| First Author | Kim TH | Year | 2014 |
| Journal | Cell Death Dis | Volume | 5 |
| Pages | e1527 | PubMed ID | 25412305 |
| Mgi Jnum | J:315864 | Mgi Id | MGI:6832265 |
| Doi | 10.1038/cddis.2014.490 | Citation | Kim TH, et al. (2014) Identification of Creb3l4 as an essential negative regulator of adipogenesis. Cell Death Dis 5:e1527 |
| abstractText | Understanding the molecular networks that regulate adipogenesis is crucial for combating obesity. However, the identity and molecular actions of negative regulators that regulate the early development of adipocytes remain poorly understood. In this study, we investigated the role of CREB3L4, a member of the CREB3-like family, in the regulation of adiposity. Constitutive overexpression of CREB3L4 resulted in the inhibition of adipocyte differentiation, whereas knockdown of Creb3l4 expression caused differentiation of preadipocytes into mature adipocytes, bypassing the mitotic clonal expansion step. In 3T3-L1 preadipocytes, Creb3l4 knockdown resulted in increased expression of peroxisome proliferator-activated receptor gamma (PPARgamma2) and CCAAT/enhancer binding protein (C/EBPalpha), either by increasing the protein stability of C/EBPbeta or by decreasing the expression of GATA3, a negative regulator of PPARgamma2 expression. Consequently, increased PPARgamma2 and C/EBPalpha levels induced adipocyte differentiation, even in the presence of minimal hormonal inducer. Thus, it can be speculated that CREB3L4 has a role as gatekeeper, inhibiting adipogenesis in 3T3-L1 preadipocytes. Moreover, adipocytes of Creb3l4-knockout mice showed hyperplasia caused by increased adipogenesis, and exhibited improved glucose tolerance and insulin sensitivity, as compared with littermate wild-type mice. These results raise the possibility that Creb3l4 could be a useful therapeutic target in the fight against obesity and metabolic syndrome. |
